Skip to content
Clinical trial

Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial

Sep 2026 · Nature Medicine · Vol 32, pp. 3302 - 3312 · 1 citation · 50 references
Medicine
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.